Clinical Data

weight loss scale weigh measure tape obesity overweight

Biotech

Zealand's dual agonist tied to 11% weight loss in phase 1b

A higher dose of Zealand Pharma's GLP-1/GLP-2 receptor dual agonist reduced mean body weight by 11.6% after 28 weeks in a phase 1b trial.

Gabrielle Masson Jun 18, 2025 3:00pm

obesity overweight weight loss weigh

Scholar Rock's SMA drug helps Zepbound patients retain muscle

Jun 18, 2025 9:10am

overcome ladder win beat advance obstacle maze

Immuneering sees 94% survival at 6 months in pancreatic cancer

Jun 17, 2025 10:55am

heart

Mineralys drug lowers blood pressure in yet another clinical win

Jun 17, 2025 9:25am

White arrow on a road pointing to the rising sun

Ventyx posts Parkinson's data ahead of potential Sanofi talks

Jun 17, 2025 9:05am

Fierce Pharma

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Jun 16, 2025 10:58am